Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 400
1 331 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$254.49 |
+0%
|
$449.6B |
|
|
|
Amgen Inc
AMGN
|
$366.29 |
-1.4%
|
$197.7B |
|
|
|
Gilead Sciences Inc
GILD
|
$134.28 |
-1.5%
|
$166.7B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$485.65 |
-0.1%
|
$123.3B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$676.69 |
-0.3%
|
$70.9B |
|
|
|
argenx SE
ARGX
|
€752 |
+0.2%
|
$54B |
|
|
|
CSL Ltd
CSL
|
AU$123.32 |
+1.1%
|
$41.3B |
|
|
|
Revolution Medicines Inc
RVMD
|
$186.16 |
+3.9%
|
$39.6B |
|
|
|
Natera Inc
NTRA
|
$271.39 |
+0.6%
|
$38.9B |
1 326 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
